V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013991 | 270009568 | null | 87 | Curative (C) | 2014-12-23 | 2015-01-08 | DHAP | 02 | Y | 270016339 | DHAP |
| 270013992 | 270009569 | 1.77 | 77.6 | Curative (C) | 2013-12-27 | 2013-12-27 | DHAP | 2 | N | 270016344 | DHAP |
| 270013993 | 270009569 | 1.71 | 97 | Palliative (P) | 2016-12-12 | 2016-12-15 | CHLVPP | 02 | N | 270016344 | CHLVPP |
| 270013994 | 270009571 | 1.75 | 84 | Curative (C) | 2017-12-15 | 2018-01-16 | null | 2 | Y | 270016356 | NOT MATCHED |
| 270013995 | 270014479 | 0 | 60.5 | Adjuvant (A) | 2015-01-15 | 2015-02-05 | CAPECITABINE + IRINOTECAN | N | N | 270016358 | CAPECITABINE + IRINOTECAN |
| 270013996 | 270014480 | null | 83.25 | Adjuvant (A) | 2014-06-23 | 2015-02-16 | Fluorouricil + Folonic Acid (MdG) | N | Y | 270016359 | FLUOROURACIL |
| 270013997 | 270014480 | 1.78 | 91.4 | Curative (C) | 2016-04-29 | 2016-05-03 | DHAP | 02 | N | 270016359 | DHAP |
| 270013998 | 270009576 | 1.58 | null | Curative (C) | 2018-06-14 | 2018-06-21 | DHAP | 02 | N | 270016361 | DHAP |
| 270013999 | 270009578 | 1.81 | 57.2 | Curative (C) | 2014-06-04 | 2014-06-27 | CHLVPP | 2 | N | 270016362 | CHLVPP |
| 270014000 | 270009578 | 1.69 | null | Curative (C) | 2018-04-26 | 2018-05-05 | DHAP | N | null | 270016362 | DHAP |
| 270014001 | 270009582 | null | 74.4 | Neo-adjuvant (N) | 2013-08-01 | 2013-09-01 | Capecitabine (21 day) + Irinotecan | N | null | 270016371 | CAPECITABINE + IRINOTECAN |
| 270014002 | 270009584 | null | null | Neo-adjuvant (N) | 2014-09-25 | 2014-10-03 | Bevacizumab + Oxaliplatin +MdG | N | null | 270016378 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014003 | 270009586 | 1.85 | 92 | Neo-adjuvant (N) | 2017-11-26 | 2017-12-01 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270016380 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014004 | 270014484 | 1.66 | 47.1 | Neo-adjuvant (N) | 2016-07-28 | 2016-11-18 | CAPECITABINE + RT | N | N | 270016380 | CAPECITABINE + RT |
| 270014005 | 270009587 | 1.67 | 68 | Neo-adjuvant (N) | 2013-06-29 | 2013-06-30 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270016384 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014006 | 270009589 | null | null | Not known (9) | 2014-03-30 | 2014-04-06 | FLUOROURACIL | N | N | 270016386 | FLUOROURACIL |
| 270014007 | 270014486 | 1.77 | 82.8 | Curative (C) | null | 2014-07-31 | null | 99 | null | 270016387 | NOT MATCHED |
| 270014008 | 270009591 | 1.79 | 77.6 | Adjuvant (A) | 2014-08-17 | 2014-08-17 | Cetuximab + Radiotherapy Load | N | N | 270016396 | CETUXIMAB + RT |
| 270014009 | 270009591 | 1.77 | 87.6 | null | 2018-12-21 | 2019-01-04 | CHLVPP | 2 | N | 270016396 | CHLVPP |
| 270014010 | 270009591 | 1.84 | null | Disease modification (D) | 2018-12-18 | 2018-12-25 | DHAP | N | null | 270016396 | DHAP |
| 270014011 | 270009592 | 1.6 | 65 | Not known (9) | 2016-10-31 | 2017-09-07 | FLUOROURACIL | 2 | N | 270016400 | FLUOROURACIL |
| 270014012 | 270009593 | 1.65 | 51 | Palliative (P) | 2014-01-28 | 2014-02-20 | CAPECITABINE + IRINOTECAN | N | N | 270016400 | CAPECITABINE + IRINOTECAN |
| 270014013 | 270018415 | 1.82 | 57 | Neo-adjuvant (N) | 2014-09-09 | 2014-09-09 | CAPECITABINE + RT | 02 | N | 270016405 | CAPECITABINE + RT |
| 270014014 | 270014490 | 1.74 | 78.7 | Disease modification (D) | 2014-07-22 | 2014-08-30 | Trifluridine + Tipiracil | N | N | 270016406 | TRIFLURIDINE + TIPIRACIL |
| 270014016 | 270009600 | 1.7 | 82.8 | Neo-adjuvant (N) | 2013-04-04 | 2013-06-07 | Capecitabine 35days + RT | N | N | 270016413 | CAPECITABINE + RT |
| 270014017 | 270009601 | 1.69 | 100.9 | Adjuvant (A) | 2017-05-21 | 2017-05-21 | DHAP | 02 | N | 270016414 | DHAP |
| 270014018 | 270016982 | 1.64 | 58.7 | Adjuvant (A) | 2017-05-08 | 2017-05-09 | CHOP R - 21 days | 02 | null | 270016418 | CHOP R |
| 270014019 | 270009604 | 1.8 | 53.5 | Adjuvant (A) | 2018-01-28 | 2018-01-28 | CHLVPP | 02 | null | 270016421 | CHLVPP |
| 270014020 | 270009606 | 1.62 | 62 | Palliative (P) | 2014-03-24 | 2014-04-14 | CISPLATIN + FLUOROURACIL | 02 | Y | 270016423 | CISPLATIN + FLUOROURACIL |
| 270014021 | 270009606 | 1.81 | 88.7 | Curative (C) | 2014-03-31 | 2014-04-01 | null | 02 | null | 270016423 | NOT MATCHED |
| 270014022 | 270009606 | 1.77 | 46 | null | 2016-02-09 | 2016-02-14 | Bevacizumab + Oxaliplatin +MdG | 02 | Y | 270016423 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014023 | 270014496 | 1.61 | 55.8 | Adjuvant (A) | 2014-05-13 | 2014-05-13 | Cetuximab + Radiotherapy Maint | 99 | null | 270016428 | CETUXIMAB + RT |
| 270014024 | 270014496 | 1.76 | 66 | Neo-adjuvant (N) | 2016-08-18 | 2016-10-25 | Bevacizumab + Oxaliplatin +MdG | 99 | null | 270016428 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014025 | 270014496 | 1.58 | 98 | Adjuvant (A) | 2017-05-26 | 2017-05-28 | Capecitabine (14 day) + Irinotecan | 2 | N | 270016428 | CAPECITABINE + IRINOTECAN |
| 270014026 | 270018419 | null | 100 | Curative (C) | 2014-11-23 | 2014-12-28 | CYCLOPHOSPHAMIDE + MITOXANTRONE + VINCRISTINE | N | N | 270016438 | NOT MATCHED |
| 270014027 | 270014498 | 1.65 | null | Curative (C) | 2017-10-25 | 2017-10-27 | CHOP R - 14 days | 2 | N | 270016438 | CHOP R |
| 270014028 | 270009615 | 1.69 | 84.8 | Curative (C) | 2015-12-22 | 2015-12-25 | CISPLATIN + FLUOROURACIL | N | null | 270016443 | CISPLATIN + FLUOROURACIL |
| 270014029 | 270009617 | null | null | Palliative (P) | 2016-04-17 | 2016-04-21 | FLUOROURACIL + FOLINIC ACID | 02 | N | 270016443 | FLUOROURACIL |
| 270014030 | 270009617 | 1.77 | 87.5 | Curative (C) | null | 2014-12-22 | null | N | N | 270016443 | NOT MATCHED |
| 270014031 | 270009618 | 1.69 | 90 | Curative (C) | 2017-11-30 | 2017-11-30 | null | null | null | 270016451 | NOT MATCHED |
| 270014032 | 270009619 | null | null | Not known (9) | 2016-08-26 | 2016-08-26 | Fluorouracil + Folinic Acid Weekly | N | null | 270016454 | FLUOROURACIL |
| 270014033 | 270009620 | 1.9 | 120 | Curative (C) | 2014-04-11 | 2014-04-18 | CHOP R - 21 days | 02 | null | 270016457 | CHOP R |
| 270014034 | 270014501 | 1.74 | 77.2 | Curative (C) | 2017-04-05 | 2017-04-19 | DHAP | 02 | N | 270016459 | DHAP |
| 270014035 | 270009622 | 1.73 | 61.3 | Palliative (P) | 2018-03-06 | 2018-03-12 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016459 | FLUOROURACIL |
| 270014036 | 270016991 | 1.56 | 90 | Palliative (P) | 2014-09-09 | 2015-03-22 | Trifluridine + Tipiracil | 02 | N | 270016464 | TRIFLURIDINE + TIPIRACIL |
| 270014037 | 270009623 | null | null | Disease modification (D) | 2016-12-06 | 2016-12-17 | CHOP R | N | N | 270016470 | CHOP R |
| 270014038 | 270014503 | 1.57 | 87 | Curative (C) | 2017-09-03 | 2017-09-17 | Cetuximab + Radiotherapy Maint | N | N | 270016474 | CETUXIMAB + RT |
| 270014039 | 270014503 | 1.82 | 66 | Not known (9) | 2016-11-23 | 2016-11-27 | FLUOROURACIL | N | N | 270016474 | FLUOROURACIL |
| 270014040 | 270009625 | 1.75 | 80.3 | Curative (C) | 2013-08-03 | 2013-08-03 | DHAP | 02 | N | 270016482 | DHAP |
| 270014041 | 270009626 | 1.69 | null | Palliative (P) | 2016-11-13 | 2016-12-18 | Fluorouracil + Folinic Acid Weekly | N | Y | 270016488 | FLUOROURACIL |